Colombani, F. http://orcid.org/0000-0001-8925-7053
Sibé, M.
Kret, M.
Quintard, B.
Ravaud, A.
Saillour-Glénisson, F.
Funding for this research was provided by:
Health Services Research Grant from the French Ministry of Health (France)– PREPS Program (n°PREPS-16-241)
Article History
Received: 25 April 2019
Accepted: 28 June 2019
First Online: 12 July 2019
Ethics approval and consent to participate
: The EPOCK study protocol was approved on 26 July 2017 by institutional review boards and Ethics Committees (Comité de Protection des Personnes [CPP] du Sud-Ouest et Outre-Mer III number: 2017-A02049–44) and registered in ExternalRef removed (registration number: NCT03350776).The consent has to be collected orally according to the CPP Ethics committee. Participants are invited verbally to participate. For patients, their non-opposition has to be recorded in the medical file of the investigating centre. The participant may, at any time, object to the use of his or her data for research purposes.
: Not applicable.
: The authors declare that they have no competing interests.